These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10506904)

  • 1. Treatment of acute opioid withdrawal with ibogaine.
    Alper KR; Lotsof HS; Frenken GM; Luciano DJ; Bastiaans J
    Am J Addict; 1999; 8(3):234-42. PubMed ID: 10506904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes.
    Brown TK; Alper K
    Am J Drug Alcohol Abuse; 2018; 44(1):24-36. PubMed ID: 28541119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibogaine in acute opioid withdrawal. An open label case series.
    Alper KR; Lotsof HS; Frenken GM; Luciano DJ; Bastiaans J
    Ann N Y Acad Sci; 2000; 909():257-9. PubMed ID: 10911935
    [No Abstract]   [Full Text] [Related]  

  • 4. The ibogaine medical subculture.
    Alper KR; Lotsof HS; Kaplan CD
    J Ethnopharmacol; 2008 Jan; 115(1):9-24. PubMed ID: 18029124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Withdrawal and Craving Scores in Participants Undergoing Opioid Detoxification Utilizing Ibogaine.
    Malcolm BJ; Polanco M; Barsuglia JP
    J Psychoactive Drugs; 2018; 50(3):256-265. PubMed ID: 29608409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study.
    Noller GE; Frampton CM; Yazar-Klosinski B
    Am J Drug Alcohol Abuse; 2018; 44(1):37-46. PubMed ID: 28402682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug.
    Popik P; Layer RT; Skolnick P
    Pharmacol Rev; 1995 Jun; 47(2):235-53. PubMed ID: 7568327
    [No Abstract]   [Full Text] [Related]  

  • 8. Ibogaine in the treatment of heroin withdrawal.
    Mash DC; Kovera CA; Pablo J; Tyndale R; Ervin FR; Kamlet JD; Hearn WL
    Alkaloids Chem Biol; 2001; 56():155-71. PubMed ID: 11705106
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ibogaine--the substance for treatment of toxicomania. Neurochemical and pharmacological action].
    Kazlauskas S; Kontrimaviciūte V; Sveikata A
    Medicina (Kaunas); 2004; 40(3):216-9. PubMed ID: 15064541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Mixed-Method Analysis of Persisting Effects Associated with Positive Outcomes Following Ibogaine Detoxification.
    Davis AK; Renn E; Windham-Herman AM; Polanco M; Barsuglia JP
    J Psychoactive Drugs; 2018; 50(4):287-297. PubMed ID: 30020025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 18-methoxycoronaridine on acute signs of morphine withdrawal in rats.
    Rho B; Glick SD
    Neuroreport; 1998 May; 9(7):1283-5. PubMed ID: 9631413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the toxicity and therapeutic potential of ibogaine in the treatment of chronic opioid abuse.
    Luz M; Mash DC
    Expert Opin Drug Metab Toxicol; 2021 Sep; 17(9):1019-1022. PubMed ID: 34139922
    [No Abstract]   [Full Text] [Related]  

  • 13. IUPHAR - invited review - Ibogaine - A legacy within the current renaissance of psychedelic therapy.
    Mash DC
    Pharmacol Res; 2023 Apr; 190():106620. PubMed ID: 36907284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary investigation of ibogaine: case reports and recommendations for further study.
    Sheppard SG
    J Subst Abuse Treat; 1994; 11(4):379-85. PubMed ID: 7966509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes.
    Mash DC; Duque L; Page B; Allen-Ferdinand K
    Front Pharmacol; 2018; 9():529. PubMed ID: 29922156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers.
    Corkery JM
    Prog Brain Res; 2018; 242():217-257. PubMed ID: 30471681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating drug dependence with the aid of ibogaine: a retrospective study.
    Schenberg EE; de Castro Comis MA; Chaves BR; da Silveira DX
    J Psychopharmacol; 2014 Nov; 28(11):993-1000. PubMed ID: 25271214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action.
    Glick SD; Maisonneuve IM; Szumlinski KK
    Ann N Y Acad Sci; 2000 Sep; 914():369-86. PubMed ID: 11085336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibogaine and Subjective Experience: Transformative States and Psychopharmacotherapy in the Treatment of Opioid Use Disorder.
    Brown TK; Noller GE; Denenberg JO
    J Psychoactive Drugs; 2019; 51(2):155-165. PubMed ID: 30967101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DARK Classics in Chemical Neuroscience: Ibogaine.
    Wasko MJ; Witt-Enderby PA; Surratt CK
    ACS Chem Neurosci; 2018 Oct; 9(10):2475-2483. PubMed ID: 30216039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.